Additionally, LKB1 is an important tumor suppressor in adenocarcinomas, specifically non‐small cell lung cancer adenocarcinomas, where LKB1 is mutated in 33% of all cases 13, 14, 15. This evidence concerns the gene STK11 and neoplasm.